CAR T Cells Targeting MISIIR for the Treatment of Ovarian Cancer and Other Gynecologic Malignancies
Alba Rodríguez-García(Fundació Clínic per a la Recerca Biomèdica), Daniel J. Powell(Democritus University of Thrace)
Cited by 46
Related Papers
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
|Nature Communications|2021|320
CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape
|Frontiers in Immunology|2020|310
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety
|Cancer Cell|2022|64
CD5 deletion enhances the antitumor activity of adoptive T cell therapies
|Science Immunology|2024|45